Veru Inc (VERU) Live Share Price, Invest From India

Veru Inc Stock Performance

as on December 9, 2025 at 2:29 am IST

Day's Low
Day's High
$2.46
Day's Price Range
$2.67
$2.65
7.17%
Downside
0.75%
Upside
52 Week's Low
52 Week's High
$2.11
52-Week Price Range
$14.2
$2.65
20.38%
Downside
435.85%
Upside

Veru Inc share price movements today

Previous Close: $2.49
Open: $2.46
Volume: 631.4K
Day's Low - High: $2.46 - $2.67
52 Week Low - High: $2.11 - $14.2

Veru Inc Historical Returns

1 Month Return: -2.73 %
3 Month Return: -26.11 %
1 Year Return: -65.12 %
3 Year Return: -95.73 %
5 Year Return: -92.33 %

Veru Inc Stock Fundamentals & Key Indicators

Check Veru Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$40.0M

EPS (TTM)

-1.55

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0.41

Industry PE ratio

14.63725

PEG Ratio

EBITDA

-38.2M

Revenue (TTM)

16.9M

Profit Margin

-193.71%

Return On Equity TTM

-106.02%

Veru Inc Stock Valuation

Track how Veru Inc P/E has moved over time to understand its valuation trends.

Veru Inc in the last 5 years

Overview
Trends

Lowest (-196.72x)

June 30, 2022

Today (0.41x)

December 8, 2025

Industry (14.64x)

December 8, 2025

Highest (-6.84x)

September 30, 2025

LowHigh

Today’s Price to Earnings Ratio: 0.41x

Veru Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Veru Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Veru Inc	BUY	$40.0M	-92.33%	0.41	-193.71%
Insmed Incorporated	BUY	$43.5B	418.42%	-16.34	-264.83%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	257.77%	1431.62	1.36%
Vertex Pharmaceuticals Incorporated	BUY	$116.8B	98.18%	32.05	31.35%
Regeneron Pharmaceuticals, Inc.	BUY	$76.1B	44.5%	17.21	32.13%

Stock Returns calculator for Veru Inc Stock including INR - Dollar returns

The Veru Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Veru Inc investment value today

Current value as on today

₹43,254

Returns

₹56,746

(-56.75%)

Returns from Veru Inc Stock

₹62,885 (-62.89%)

Dollar Returns*

₹6,139 (+6.14%)

Analyst Recommendation on Veru Inc Stock

Based on 9 analysts

BUY

88.89%

Buy

11.11%

Hold

0.00%

Sell

Based on 9 analysts, 88.89% of analysts recommend a 'BUY' rating for Veru Inc. Average target price of $19.75

Veru Inc Share Price Target

Get share price movements and forecasts by analysts on Veru Inc.

What analysts predicted

86.58%UPSIDE

Target Price

$19.75

Current Price

$2.65

Analyzed by

9 Analysts

Target

$19.75

Veru Inc target price $19.75, a slight upside of 86.58% compared to current price of $2.65. According to 9 analysts rating.

Veru Inc Stock’s Investor Sentiment and Interest

Search interest for Veru Inc Stock has decreased by -15% in the last 30 days, reflecting a downward trend in search activity.

Time period: November 9, 2025 to December 9, 2025

Change:-15% versus previous 30 day period

Veru Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	6	3	3	-	4	3	6	-	-	-
Gross Profit	4	1	1	1	0	1	2	0	0	0
Operating Income	-34	4	-11	-8	-9	-10	-8	-10	-8	-7
EBITDA	-33	-12	-10	-	-9	-10	-7	-10	-9	-7
Interest Expense	0	0	0	0	0	0	0	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-33	6	-10	-7	-9	-10	-8	-1	-7	-7
Income Tax Expense	0	0	0	-	0	0	0	-7	-	-
Net Income	-33	6	-23	-8	-10	-10	-8	-8	-7	-7
Net Profit Margin	-513.04%	188.98%	-615.43%	0.00%	-242.45%	-277.42%	-128.15%	0.00%	0.00%	0.00%

Veru Inc Annual Profit & Loss

All numbers in Millions USD

	Sep 2015	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Total Revenue	32	22	13	15	31	42	61	39	16	16
Gross Profit	18	13	7	8	21	30	47	30	7	5
Operating Income	6	3	-8	-20	-6	-14	12	-83	-93	-36
EBITDA	7	4	-8	-20	-5	-14	9	-83	-89	-36
Interest Expense	0	3	2	2	4	4	4	4	2	0
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	6	2	-8	-23	-12	-20	4	-83	-92	-37
Income Tax Expense	2	2	-1	0	0	-1	-3	0	0	0
Net Income	4	0	-6	-23	-12	-18	7	-83	-93	-37
Net Profit Margin	13.33%	1.56%	-48.42%	-150.89%	-37.79%	-44.55%	12.07%	-212.88%	-571.60%	-223.86%

Veru Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	6	-23	-8	-10	-10	-8	-8	-7	-7
Operating Cash Flow	-18	-9	-6	-5	-5	-4	-11	-7	-5
Investing Cash Flow	5	0	-	0	0	0	17	1	0
Financing Cash Flow	5	2	36	0	0	-	-4	-	-
Change in Cash	-7	-6	30	-5	-5	-4	1	-6	-5

Veru Inc Annual Cash Flow

All numbers in Millions USD

	Sep 2016	Sep 2017	Sep 2018	Sep 2019	Sep 2020	Sep 2021	Sep 2022	Sep 2023	Sep 2024
Net Income	0	-6	-23	-12	-18	7	-83	-93	-37
Operating Cash Flow	-1	0	-11	-5	-1	-15	-47	-88	-21
Investing Cash Flow	0	0	0	0	0	14	4	6	0
Financing Cash Flow	12	12	12	8	9	109	1	11	36
Change in Cash	-1	0	0	2	7	108	-42	-70	15

Global Institutional Holdings in Veru Inc

Funds	Holdings
BlackRock Inc	5.9%
MPM Oncology Impact Management LP	4.5%
Vanguard Group Inc	4.37%
State Street Corp	1.52%
UBS Group AG	1.34%

See all

Insights on Veru Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 3.95M → 6.65M (in $), with an average increase of 40.6% per quarter
POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -8.94M → -7.33M (in $), with an average increase of 10.5% per quarter
NO EFFECT
Against Peers
In the last 1 year, Insmed Incorporated has given 170.6% return, outperforming this stock by 235.7%
NO EFFECT
Against Peers
In the last 3 years, Insmed Incorporated has given 995.0% return, outperforming this stock by 1090.7%
NEGATIVE IMPACT
Price Dip
In the last 6 months, VERU stock has moved down by -59.7%

About Veru Inc

the female health company/veru healthcare is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. to realize this goal, veru healthcare has three divisions: pharmaceutical and devices, consumer health products, and public sector. for men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout, and sexual dysfunction. women’s health has product candidates for female sexual health and advanced breast and ovarian cancers and markets fc2, a disposable contraceptive device, to ob gyn physicians and is the only female condom approved by fda that offers dual protection against sexually transmitted infections, including hiv/aids and the zika virus, and unintended pregnancy. since the female health company began distributing fc2 in 2007, the product has been shipped to 144 countries

Organisation	Veru Inc
Headquarters	2916 North Miami Avenue, Miami, FL, United States, 33127
Industry	Consumer Non-Durables
CEO	Dr. Mitchell S. Steiner F.A.C.S., M.D.
E-voting on shares	Click here to vote

Key Management of Veru Inc

Name	Title
Dr. Harry D. Fisch F.A.C.S., M.D.	Vice Chairman & Chief Corporate Officer
Dr. K. Gary Barnette Ph.D.	Chief Scientific Officer
Ms. Michele Greco CPA	CFO & Chief Administrative Officer
Mr. Michael J. Purvis J.D.	Executive VP, General Counsel & Corporate Strategy and Secretary
Mr. Kevin J. Gilbert CPA, J.D.	Executive Vice President of Corporate Development
Mr. Philip R. Greenberg J.D.	Executive VP & Deputy General Counsel
Dr. Domingo Rodriguez M.D.	Executive Vice President of Global Clinical Operations
Dr. Mitchell S. Steiner F.A.C.S., M.D.	Chairman, President & CEO
Mr. Samuel Fisch	Executive Director of Investor Relations & Corporate Communications
Mr. Martin Tayler	Executive Vice President of FC2 Global Operations

FAQs

What is Veru Inc share price today?

Veru Inc share price today is $2.65 as on December 9, 2025 at 2:29 am IST at the close of the market. Veru Inc share today touched a day high of $2.67 and a low of $2.46.

What is the 52 week high and 52 week low for Veru Inc share?

Veru Inc share touched a 52 week high of $14.2 on January 24, 2025 and a 52 week low of $2.11 on November 20, 2025. Veru Inc stock price today i.e. December 9, 2025 at 2:29 am IST is closed at $2.65,which is 81.34% down from its 52 week high and 25.59% up from its 52 week low.

What is Veru Inc's market capitalisation today?

Veru Inc market capitalisation is $0.00T as on December 9, 2025 at 2:29 am IST.

How to invest in Veru Inc Stock (VERU) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Veru Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Veru Inc Shares that will get you 0.5660 shares as per Veru Inc share price of $2.65 per share as on December 9, 2025 at 2:29 am IST.

What is the minimum amount required to buy Veru Inc Stock (VERU) from India?

Indian investors can start investing in Veru Inc (VERU) shares with as little as ₹90.066 or $1 (as of December 9, 2025 at 4:48 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹900.66 in Veru Inc stock (as per the Rupee-Dollar exchange rate as on December 9, 2025 at 4:48 am IST). Based on Veru Inc share’s latest price of $2.65 as on December 9, 2025 at 2:29 am IST, you will get 3.7736 shares of Veru Inc. Learn more about fractional shares .

What are the returns that Veru Inc has given to Indian investors in the last 5 years?

Veru Inc stock has given -92.33% share price returns and 22% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?